High molecular weight adiponectin, but not hexameric or trimeric forms, correlates with markers of metabolic syndrome and liver injury.
No takes yet. Share an insight, caveat, or question.
Supports HMW adiponectin as metabolic biomarker candidate; cross-sectional data leave causal and clinical roles open.
Liu et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: